Computational Analysis of Hemagglutinin Evolution and Receptor Binding Specificity in Zoonotic Influenza A Viruses

Introduction

Influenza A viruses (IAVs) represent a persistent zoonotic threat to animal and human populations due to their capacity for rapid genetic change and interspecies transmission [1, 2]. The hemagglutinin (HA) glycoprotein is the primary determinant of host range and viral entry, mediating attachment to sialic acid receptors on host epithelial cells [3, 4]. Computational analysis of HA evolution has become indispensable for tracking antigenic drift, predicting receptor binding specificity, and assessing pandemic risk in veterinary and zoonotic contexts [5, 6]. This article reviews the bioinformatics methodologies employed to characterize HA sequence variation, phylogenetic dynamics, and structural determinants of receptor binding in zoonotic IAVs, with a focus on avian and swine reservoirs.

Sequence Surveillance and Data Repositories

The foundation of computational HA analysis rests on large-scale genomic surveillance. Global initiatives such as the Global Initiative on Sharing All Influenza Data (GISAID) and the Influenza Research Database (IRD) provide curated repositories of HA sequences from diverse host species, including poultry, swine, and wild birds [7, 8]. These databases enable real-time monitoring of emerging mutations and facilitate comparative analyses across geographic regions and host taxa [9, 10]. Standardized nomenclature systems, as described by Neher et al., are critical for tracking genetic variation and ensuring consistent communication among surveillance networks [7]. High-throughput sequencing technologies have dramatically increased the volume of available sequence data, allowing for the detection of minor variant populations within individual hosts that may harbor adaptive mutations [11, 12].

Phylogenetic Analysis and Evolutionary Dynamics

Phylogenetic reconstruction is a core computational tool for understanding HA evolutionary history and identifying lineages with zoonotic potential [13, 2]. Maximum likelihood and Bayesian methods are commonly applied to HA nucleotide or amino acid sequences to infer ancestral relationships, estimate substitution rates, and detect sites under positive selection [5, 8]. For example, Yang et al. employed Bayesian phylodynamics to infer host roles in the global dissemination of H9N2 avian influenza viruses, revealing that certain avian species act as key reservoirs for viral maintenance and spillover [2]. Similarly, Neveau et al. used the Nextstrain platform to visualize the genetic and antigenic expansion of an H3 clade in U.S. swine, demonstrating how phylogenetic approaches can track the emergence of novel variants in livestock populations [13].

Phylogenomic analyses, which incorporate whole-genome data, provide higher resolution for outbreak investigations and transmission chain reconstruction [10, 12]. Van Poelvoorde et al. demonstrated that whole-genome-based phylogenomics improved surveillance of the Belgian 2016-2017 H3N2 season by enabling finer discrimination between co-circulating clades [10]. Such approaches are increasingly applied to zoonotic events, such as the interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle, where phylogenetic tracing revealed multiple introduction events and subsequent cattle-to-cattle transmission [1].

Structural Modeling of the Receptor Binding Site

The receptor binding site (RBS) of HA is a shallow pocket located at the membrane-distal tip of the globular head domain, composed of three structural elements: the 130-loop, the 190-helix, and the 220-loop [3, 4]. The specificity of HA for either alpha-2,3-linked sialic acids (avian-type receptors) or alpha-2,6-linked sialic acids (mammalian-type receptors) is a critical determinant of host tropism [3, 14]. Computational structural modeling, including homology modeling and molecular dynamics simulations, allows researchers to predict how specific amino acid substitutions within the RBS alter binding affinity and specificity [5, 4].

Saad-Roy et al. used deep mutational scanning data to analyze the implications of localized charge for human H1N1 HA evolution, finding that electrostatic interactions within the RBS strongly influence receptor binding avidity and antigenic escape [4]. Spruit et al. characterized the binding of avian and equine H7 IAVs to N-glycolylneuraminic acid, a sialic acid variant found in horses and certain other mammals, using structural modeling to identify key residues mediating this interaction [3]. These studies underscore the importance of integrating structural data with evolutionary analyses to predict host range shifts.

Machine Learning for Antigenic and Receptor Binding Prediction

Machine learning algorithms have been increasingly applied to predict antigenic drift and receptor binding specificity from HA sequence data [15, 16, 17]. These models are trained on large datasets of HA sequences paired with experimental measurements, such as hemagglutination inhibition (HI) titers or glycan binding array data [18, 6]. Zeller et al. developed a machine learning model that accurately predicted antigenic drift in H3 influenza A viruses circulating in swine, using features derived from HA1 amino acid sequences and phylogenetic distances [16]. The model successfully identified antigenic clusters that corresponded with vaccine mismatch, demonstrating utility for vaccine strain selection in veterinary medicine.

Convolutional neural networks have also been applied to antigenicity prediction. Lee et al. used a deep learning framework to predict antigenic variants of human H3N2 viruses and recommend vaccine strains, achieving high concordance with traditional HI-based characterization [17]. Feng et al. extended machine learning approaches to neuraminidase antigenic evolution, mapping global patterns of N2 antigenic change from 1968 to 2024 [15]. These computational tools complement experimental methods and enable rapid, high-throughput screening of emerging variants.

Deep Mutational Scanning and Fitness Landscapes

Deep mutational scanning (DMS) is a powerful experimental technique that systematically measures the functional impact of all single amino acid mutations in a protein [4, 19]. When combined with computational analysis, DMS data can reveal the fitness landscape of HA and identify mutations that confer enhanced receptor binding or immune evasion [20, 21]. Wu et al. applied DMS to major antigenic site B of human H3N2 HA, demonstrating that the local fitness landscape evolves over time as the virus accumulates mutations and population immunity shifts [19]. Welsh et al. extended this concept by showing age-dependent heterogeneity in the antigenic effects of HA mutations, with implications for understanding how prior exposure history shapes population-level susceptibility [20].

Williams et al. used a genotype network approach to analyze the criticality of the H3N2 HA fitness landscape, finding that immunity-induced selection pushes the network toward a critical state where small genetic changes can lead to large antigenic shifts [21]. These findings highlight the importance of integrating DMS data with epidemiological models to predict the emergence of antigenically novel variants.

Glycosylation and Immune Evasion

Glycosylation of the HA globular head is a major mechanism of immune evasion, as glycan shields can mask antigenic epitopes from antibody recognition [11, 22]. Computational analysis of glycosylation patterns involves predicting N-linked glycosylation sequons (Asn-X-Ser/Thr) from HA sequences and modeling the three-dimensional positions of glycans on the HA structure [22]. Chang et al. developed a data-independent acquisition mass spectrometry approach to improve statistical certainty in glycosylation similarity comparisons between IAV variants, enabling more robust computational predictions of glycan-mediated immune evasion [22].

Prasai et al. demonstrated that intrahost HA polymorphisms and culture adaptation can alter glycosylation patterns and antigenic profiles of H3N2 viruses, emphasizing the need to account for laboratory-induced changes when interpreting sequence data from surveillance programs [11]. Passage adaptation, as described by Chen et al., correlates with reduced vaccine efficacy and can introduce artifacts that confound computational predictions of antigenic evolution [23].

Workflow for Computational HA Analysis

The following Mermaid diagram illustrates a typical computational workflow for analyzing HA evolution and receptor binding specificity in zoonotic IAVs.

flowchart TD
    A[Sequence Data Acquisition], > B[Quality Control and Assembly]
    B, > C[Multiple Sequence Alignment]
    C, > D[Phylogenetic Reconstruction]
    D, > E[Positive Selection Detection]
    E, > F[Structural Modeling of RBS]
    F, > G[Receptor Binding Prediction]
    G, > H[Antigenic Drift Assessment]
    H, > I[Risk Assessment and Surveillance Reporting]
    C, > J[Glycosylation Site Prediction]
    J, > F
    D, > K[Phylodynamic Analysis]
    K, > I

The workflow begins with sequence data acquisition from public repositories, followed by quality control and assembly [7, 10]. Multiple sequence alignment is performed using tools such as MAFFT or MUSCLE, and phylogenetic trees are reconstructed using maximum likelihood or Bayesian methods [5, 2]. Positive selection detection identifies codons under diversifying pressure, often located in or near the RBS and antigenic sites [4, 19]. Structural modeling of the RBS, guided by known crystal structures, enables prediction of receptor binding specificity [3, 4]. Glycosylation site prediction adds another layer of analysis relevant to immune evasion [11, 22]. Finally, phylodynamic analysis integrates temporal and geographic data to infer transmission dynamics and inform risk assessment [1, 13].

Predicting Host Tropism Shifts

Computational prediction of host tropism shifts relies on identifying genetic signatures associated with adaptation to mammalian hosts [1, 14]. Key mutations in HA that enhance binding to alpha-2,6-linked sialic acids include Gln226Leu and Gly228Ser in H2 and H3 subtypes, as well as mutations in the 130-loop and 190-helix that alter receptor binding pocket geometry [3, 4]. Nguyen et al. documented the emergence and interstate spread of H5N1 in dairy cattle, identifying HA mutations that may facilitate replication in bovine mammary tissue [1]. Yu et al. reported the re-emergence of H7N9 viruses in humans in mainland China, with computational analysis revealing that the HA gene had acquired mutations associated with increased binding to human-type receptors [14].

Machine learning models trained on receptor binding data can classify HA sequences according to predicted host tropism [16, 17]. These models incorporate features such as amino acid identity at key positions, electrostatic potential of the RBS, and phylogenetic context [5, 4]. The integration of structural and evolutionary data improves predictive accuracy and enables early detection of variants with pandemic potential [6, 24].

Antigenic Cartography and Vaccine Strain Selection

Antigenic cartography is a computational method that visualizes the antigenic relationships between viral strains based on HI assay data [18, 15]. By projecting strains into a two-dimensional antigenic map, researchers can identify antigenic clusters and track the emergence of drift variants that escape vaccine-induced immunity [25, 13]. Kikawa et al. demonstrated that high-throughput neutralization measurements correlate strongly with the evolutionary success of human influenza strains, validating the use of antigenic cartography for predicting strain dynamics [18].

In veterinary medicine, antigenic cartography informs vaccine strain selection for poultry and swine [13, 16]. Neveau et al. used Nextstrain to visualize the antigenic evolution of H3 influenza in U.S. swine, revealing that newly emerged clades were antigenically distinct from existing vaccine strains [13]. Repeated vaccination with homologous HA can broaden antibody responses to unmatched viruses, as shown by Deng et al., but the effectiveness of this strategy depends on the antigenic distance between vaccine and circulating strains [25].

Limitations and Challenges

Despite significant advances, computational analysis of HA evolution faces several limitations. Sequence data quality and representativeness vary across geographic regions and host species, potentially biasing phylogenetic inferences [9, 8]. Passage adaptation during virus isolation can introduce mutations that alter HA antigenicity and receptor binding, complicating the interpretation of laboratory-generated data [11, 23]. Additionally, the relationship between genotype and phenotype is not always straightforward, as epistatic interactions between mutations can modulate the effects of individual substitutions [21, 19].

Computational models for predicting receptor binding specificity rely on structural data that may not capture the full conformational dynamics of HA [3, 4]. Glycan array data, while informative, may not fully recapitulate the complexity of receptor presentation on host epithelial surfaces [22, 6]. Continued integration of experimental and computational approaches, including cryo-electron microscopy and advanced molecular dynamics simulations, will be necessary to overcome these challenges [5, 6].

Future Directions

Emerging computational methods, including deep learning and foundation models, hold promise for improving predictions of HA evolution and host tropism [15, 17]. Biological foundation models trained on large corpora of viral sequences can capture complex patterns of coevolution and functional constraint, enabling more accurate forecasting of antigenic drift [5, 21]. The development of user-friendly platforms for real-time phylogenetic and antigenic analysis, such as Nextstrain, facilitates the dissemination of surveillance data to veterinary and public health stakeholders [7, 13].

Integration of HA analysis with other viral genomic segments, particularly neuraminidase, will provide a more comprehensive view of IAV evolution and immune evasion [15, 26]. Catani et al. characterized the antigenic landscape of human N2 neuraminidases, highlighting the importance of considering both surface glycoproteins in vaccine design and surveillance [26]. Cross-disciplinary collaboration between virologists, computational biologists, and epidemiologists will be essential for translating genomic data into actionable risk assessments and control strategies [1, 24].

Conclusion

Computational analysis of hemagglutinin evolution and receptor binding specificity is a cornerstone of zoonotic influenza surveillance and pandemic preparedness. Sequence surveillance, phylogenetic reconstruction, structural modeling, and machine learning collectively enable the detection of emerging variants, prediction of host tropism shifts, and informed vaccine strain selection. Continued investment in bioinformatics infrastructure and methodological innovation will enhance our ability to anticipate and mitigate the impact of zoonotic influenza A viruses on animal and human health.

References

[1] Nguyen TQ, Hutter CR, Markin A, et al. Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle in the United States. Science. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40273240/

[2] Yang J, Xie D, Nie Z, et al. Inferring host roles in bayesian phylodynamics of global avian influenza A virus H9N2. Virology. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31586866/

[3] Spruit CM, Zhu X, Tomris I, et al. N-Glycolylneuraminic Acid Binding of Avian and Equine H7 Influenza A Viruses. J Virol. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35044215/

[4] Saad-Roy CM, Arinaminpathy N, Wingreen NS, et al. Implications of localized charge for human influenza A H1N1 hemagglutinin evolution: Insights from deep mutational scans. PLoS Comput Biol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32584807/

[5] Meijers M, Ruchnewitz D, Eberhardt J, et al. Concepts and Methods for Predicting Viral Evolution. Methods Mol Biol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39890732/

[6] Wang Y, Tang CY, Wan XF. Antigenic characterization of influenza and SARS-CoV-2 viruses. Anal Bioanal Chem. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/34905077/

[7] Neher RA, Huddleston J, Bedford T, et al. Nomenclature for Tracking of Genetic Variation of Seasonal Influenza Viruses. Influenza Other Respir Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41688063/

[8] Nabakooza G, Galiwango R, Frost SDW, et al. Molecular Epidemiology and Evolutionary Dynamics of Human Influenza Type-A Viruses in Africa: A Systematic Review. Microorganisms. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35630344/

[9] Nabakooza G, Owuor DC, de Laurent ZR, et al. Phylogenomic analysis uncovers a 9-year variation of Uganda influenza type-A strains from the WHO-recommended vaccines and other Africa strains. Sci Rep. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37015946/

[10] Van Poelvoorde LAE, Bogaerts B, Fu Q, et al. Whole-genome-based phylogenomic analysis of the Belgian 2016-2017 influenza A(H3N2) outbreak season allows improved surveillance. Microb Genom. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34477544/

[11] Prasai K, Yang Z, Guan M, et al. Intrahost HA polymorphisms and culture adaptation shape antigenic profiles of H3N2 influenza viruses. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41498543/

[12] Roy S, Hartley J, Dunn H, et al. Whole-genome Sequencing Provides Data for Stratifying Infection Prevention and Control Management of Nosocomial Influenza A. Clin Infect Dis. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30993315/

[13] Neveau MN, Zeller MA, Kaplan BS, et al. Genetic and Antigenic Characterization of an Expanding H3 Influenza A Virus Clade in U.S. Swine Visualized by Nextstrain. mSphere. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35766502/

[14] Yu D, Xiang G, Zhu W, et al. The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019. Euro Surveill. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/31138362/

[15] Feng J, Shi R, Zhou H, et al. Mapping the Global Antigenic Evolution of Human Influenza A/H3N2 Neuraminidase Based on a Machine Learning Model - 1968-2024. China CDC Wkly. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40832063/

[16] Zeller MA, Gauger PC, Arendsee ZW, et al. Machine Learning Prediction and Experimental Validation of Antigenic Drift in H3 Influenza A Viruses in Swine. mSphere. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33731472/

[17] Lee EK, Tian H, Nakaya HI. Antigenicity prediction and vaccine recommendation of human influenza virus A (H3N2) using convolutional neural networks. Hum Vaccin Immunother. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32750260/

[18] Kikawa C, Loes AN, Huddleston J, et al. High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains. Elife. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41725518/

[19] Wu NC, Otwinowski J, Thompson AJ, et al. Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape. Nat Commun. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32144244/

[20] Welsh FC, Eguia RT, Lee JM, et al. Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin. Cell Host Microbe. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39032493/

[21] Williams BJM, Ogbunugafor CB, Althouse BM, et al. Immunity-induced criticality of the genotype network of influenza A (H3N2) hemagglutinin. PNAS Nexus. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36060623/

[22] Chang D, Klein J, Hackett WE, et al. Improving Statistical Certainty of Glycosylation Similarity between Influenza A Virus Variants Using Data-Independent Acquisition Mass Spectrometry. Mol Cell Proteomics. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/36103992/

[23] Chen H, Alvarez JJS, Ng SH, et al. Passage Adaptation Correlates With the Reduced Efficacy of the Influenza Vaccine. Clin Infect Dis. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30561532/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[24] Castro LA, Bedford T, Ancel Meyers L. Early prediction of antigenic transitions for influenza A/H3N2. PLoS Comput Biol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32069282/

[25] Deng Y, Tang M, Ross TM, et al. Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses. Elife. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41231113/

[26] Catani JPP, Smet A, Ysenbaert T, et al. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017. Elife. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38805550/

[27] Loes AN, Tarabi RAL, Li SH, et al. Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42200639/

[28] Akhtar A, Styles TM, Gu C, et al. Influenza vaccine based on AS03-adjuvanted chimeric HA induces long-lived stalk-specific plasma cells in bone marrow and lymph nodes of nonhuman primates. Nat Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41094203/

[29] Duwe S, Oh DY, Wedde M, et al. Atypical Influenza A(H3N2) Activity Patterns in Germany, 2021-2023, and Characterization of Newly Emerged Virus Clades. J Med Virol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40772603/

[30] Loes AN, Tarabi RAL, Huddleston J, et al. High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains. J Virol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39315814/

[31] Yehia N, Rabie N, Adel A, et al. Differential replication characteristic of reassortant avian influenza A viruses H5N8 clade 2.3.4.4b in Madin-Darby canine kidney cell. Poult Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37267711/

[32] Cao Y, Liu H, Liu D, et al. Hemagglutinin Gene Variation Rate of H9N2 Avian Influenza Virus by Vaccine Intervention in China. Viruses. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35632783/

[33] Wang MH, Lou J, Cao L, et al. Characterization of key amino acid substitutions and dynamics of the influenza virus H3N2 hemagglutinin. J Infect. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34627840/

[34] Suntronwong N, Klinfueng S, Korkong S, et al. Characterizing genetic and antigenic divergence from vaccine strain of influenza A and B viruses circulating in Thailand, 2017-2020. Sci Rep. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33437008/

[35] Criado MF, Sá E Silva M, Lee DH, et al. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses. J Virol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32999029/